CRISM Therapeutics Company Description

CRISM Therapeutics Corporation focuses on drug delivery technology to improve the clinical performance of cancer drugs as treatments for solid tumors.

Its lead product, ChemoSeed that can be implanted directly into a tumor or the resection margin following the removal of a tumor, ensuring effective therapeutic concentrations of chemotherapy drugs directly reach the tumor tissue.

Its ChemoSeed used for treatment of gliomas, a brain tumor. The company was founded in 2016 and is based in Road Town, the British Virgin Islands.

CRISM Therapeutics Corporation

Country	British Virgin Islands
Founded	2016
Industry	Biotechnology
Sector	Healthcare
Employees	4
CEO	Robin Young

Contact Details

Address: Kingston Chambers Road Town British Virgin Islands
Website	crismtherapeutics.com

Stock Details

Ticker Symbol	CRTX
Exchange	London Stock Exchange AIM
Fiscal Year	January - December
Reporting Currency	GBP
ISIN Number	VGG042401262
SIC Code	1000

Key Executives

Name	Position
Robin Young	Chief Executive Officer
Ae Swanson	Chief Operating Officer